Gene Panel Testing

Gene Panel Testing involves simultaneous analysis of selected genes associated with specific diseases or biological pathways using targeted sequencing approaches. Panels focus on clinically relevant genes, providing efficient and cost-effective alternatives to whole genome sequencing while maintaining diagnostic accuracy.

The biopharmaceutical industry employs gene panels in clinical trials to identify eligible patients, confirm diagnoses, and support companion diagnostics. Oncology trials frequently use gene panels to detect actionable mutations guiding targeted therapy selection. Regulatory submissions may include panel-based biomarker strategies supporting personalised medicine claims. As precision medicine adoption increases, gene panel testing continues enabling faster, clinically actionable genomic insights supporting treatment decisions and clinical trial enrolment.